Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Treatment and Docetaxel in Metastatic Prostate Cancer
NCT00104715Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 2004
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by Unicancer. Started Oct 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00104715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104715.